The Therapeutic Potential of Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Narrative Review
Journal of Clinical Medicine · 27.11.2025 · 14 (23) · 8415
DOI: 10.3390/jcm14238415 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.11.2025. Verfasst von Aleksandra Złotowska und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Students Scientific Association by Department and Clinic of Anaesthesiology and Intensive Therapy, Faculty of Medicine, Wroclaw Medical Universit…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Increasing antimicrobial resistance (AMR) is one of the leading causes of death worldwide. The predominant pathogens that exacerbate the AMR problem are multidrug-resistant (MDR) Gram-negative bacteria (GNB). Due to the increasing adaptation of MDR GNB to commercially available antimicrobial drugs, such as carbapenems as well as third- and fourth-generation cephalosporins, pharmaceutical companies around the world have been forced to produce increasingly innovative chemotherapeutics. Cefiderocol (CFDC) is a novel injectable cephalosporin 5 generation developed by Shionogi, directed against MDR GNB, including strains resistant to carbapenems.
Results
Analysis demonstrated its significant efficacy across a wide range of in vitro and in vivo studies against MDR GNB, including Carbapenem-resistant Pseudomonas aeruginosa (CRPA), Carbapenem-resistant Acinetobacter baumannii (CRAB), and carbapenem-resistant Enterobacterales (CRE) (WHO Critical Priority Pathogens). Clinical studies have shown CFDC to be an effective drug with few adverse effects.
Conclusions
When used CFDC appropriately within antibiotic stewardship guidelines, this drug is an effective, well-tolerated targeted treatment option for patients with severe clinical conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Students Scientific Association by Department and Clinic of Anaesthesiology and Intensive Therapy, Faculty of Medicine, Wroclaw Medical University, L. Pasteura Street 1, 50-367 Wroclaw, Poland.
- Department and Clinic of Anaesthesiology and Intensive Therapy, Faculty of Medicine, Wroclaw Medical University, L. Pasteura Street 1, 50-367 Wroclaw, Poland.
ORCID-Profile: Aleksandra Złotowska, Wiesława Duszyńska
Zitieren
APA
Złotowska, A., Buzun, W. H., Pełka, K., Zalewska, Z., & Duszyńska, W. (2025). The Therapeutic Potential of Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Narrative Review. Journal of Clinical Medicine, 14(23), 8415. https://doi.org/10.3390/jcm14238415
Vancouver
Złotowska A, Buzun WH, Pełka K, Zalewska Z, Duszyńska W. The Therapeutic Potential of Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Narrative Review. Journal of Clinical Medicine. 2025;14(23):8415. doi:10.3390/jcm14238415
BibTeX
@article{Zotowska2025,
author = {Złotowska, Aleksandra and Buzun, Wiktoria Hanna and Pełka, Karolina and Zalewska, Zuzanna and Duszyńska, Wiesława},
title = {The Therapeutic Potential of Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {23},
pages = {8415},
doi = {10.3390/jcm14238415}
}
EUVIMED